{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T20:26:13Z","timestamp":1727123173083},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Chinese Academy of Medical Science Innovation Fund for Medical Sciences","award":["2021-I2M-C&T-B-061"],"award-info":[{"award-number":["2021-I2M-C&T-B-061"]}]},{"name":"Beijing Hope Run Special Fund of Cancer Foundation of China","award":["LC2022A22"],"award-info":[{"award-number":["LC2022A22"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"DOI":"10.1186\/s12931-024-02941-9","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T16:03:19Z","timestamp":1726502599000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum tumor markers: potential indicators for occult lymph node metastasis in clinical T1\u2009\u2212\u20092N0M0 small cell lung cancer patients"],"prefix":"10.1186","volume":"25","author":[{"given":"Xu","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-Wen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiu-Ming","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,16]]},"reference":[{"key":"2941_CR1","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s12931-024-02852-9","volume":"25","author":"X Jiang","year":"2024","unstructured":"Jiang X, Luo C, Peng X, Zhang J, Yang L, Liu LZ, Cui YF, Liu MW, Miao L, Jiang JM, et al. Incidence rate of occult lymph node metastasis in clinical T(1\u20132)N(0)M(0) small cell lung cancer patients and radiomic prediction based on contrast-enhanced CT imaging: a multicenter study: original research. Respir Res. 2024;25:226.","journal-title":"Respir Res"},{"key":"2941_CR2","unstructured":"Small Cell Lung Cancer. In: NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) Small Cell Lung Cancer Version 3.2024. National Comprehensive Cancer Network. 2024. https:\/\/www.nccn.org. Accessed 21 Jul 2024."},{"key":"2941_CR3","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1016\/j.ccell.2021.09.008","volume":"39","author":"JM Chan","year":"2021","unstructured":"Chan JM, Quintanal-Villalonga \u00c1, Gao VR, Xie Y, Allaj V, Chaudhary O, Masilionis I, Egger J, Chow A, Walle T, et al. Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer. Cancer Cell. 2021;39:1479\u2013e14961418.","journal-title":"Cancer Cell"},{"key":"2941_CR4","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1186\/s12885-022-09728-5","volume":"22","author":"J Yuan","year":"2022","unstructured":"Yuan J, Sun Y, Wang K, Wang Z, Li D, Fan M, Bu X, Chen J, Wu Z, Geng H, et al. Development and validation of reassigned CEA, CYFRA21-1 and NSE-based models for lung cancer diagnosis and prognosis prediction. BMC Cancer. 2022;22:686.","journal-title":"BMC Cancer"},{"key":"2941_CR5","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12885-017-3070-6","volume":"17","author":"L Zhang","year":"2017","unstructured":"Zhang L, Liu D, Li L, Pu D, Zhou P, Jing Y, Yu H, Wang Y, Zhu Y, He Y, et al. The important role of circulating CYFRA21-1 in metastasis diagnosis and prognostic value compared with carcinoembryonic antigen and neuron-specific enolase in lung cancer patients. BMC Cancer. 2017;17:96.","journal-title":"BMC Cancer"},{"key":"2941_CR6","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12967-019-1828-0","volume":"17","author":"MG Dal Bello","year":"2019","unstructured":"Dal Bello MG, Filiberti RA, Alama A, Orengo AM, Mussap M, Coco S, Vanni I, Boccardo S, Rijavec E, Genova C, et al. The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients. J Transl Med. 2019;17:74.","journal-title":"J Transl Med"},{"key":"2941_CR7","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1093\/labmed\/lmac122","volume":"54","author":"H Bi","year":"2023","unstructured":"Bi H, Yin L, Fang W, Song S, Wu S, Shen J. Association of CEA, NSE, CYFRA 21\u2009\u2013\u20091, SCC-Ag, and ProGRP with clinicopathological characteristics and chemotherapeutic outcomes of Lung Cancer. Lab Med. 2023;54:372\u20139.","journal-title":"Lab Med"},{"key":"2941_CR8","doi-asserted-by":"publisher","first-page":"7813","DOI":"10.1158\/1078-0432.CCR-08-0678","volume":"14","author":"S Holdenrieder","year":"2008","unstructured":"Holdenrieder S, von Pawel J, Dankelmann E, Duell T, Faderl B, Markus A, Siakavara M, Wagner H, Feldmann K, Hoffmann H, et al. Nucleosomes, ProGRP, NSE, CYFRA 21\u2009\u2013\u20091, and CEA in monitoring first-line chemotherapy of small cell lung cancer. Clin Cancer Res. 2008;14:7813\u201321.","journal-title":"Clin Cancer Res"},{"key":"2941_CR9","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/0277-5379(88)90154-X","volume":"24","author":"E Bork","year":"1988","unstructured":"Bork E, Hansen M, Urdal P, Paus E, Holst JJ, Schifter S, Fenger M, Engbaek F. Early detection of response in small cell bronchogenic carcinoma by changes in serum concentrations of creatine kinase, neuron specific enolase, calcitonin, ACTH, serotonin and gastrin releasing peptide. Eur J Cancer Clin Oncol. 1988;24:1033\u20138.","journal-title":"Eur J Cancer Clin Oncol"},{"key":"2941_CR10","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0169-5002(00)00205-1","volume":"32","author":"T Shibayama","year":"2001","unstructured":"Shibayama T, Ueoka H, Nishii K, Kiura K, Tabata M, Miyatake K, Kitajima T, Harada M. Complementary roles of pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in diagnosis and prognosis of small-cell lung cancer (SCLC). Lung Cancer. 2001;32:61\u20139.","journal-title":"Lung Cancer"},{"key":"2941_CR11","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1159\/000224628","volume":"30","author":"R Molina","year":"2009","unstructured":"Molina R, Aug\u00e9 JM, Bosch X, Escudero JM, Vi\u00f1olas N, Marrades R, Ram\u00edrez J, Carcereny E, Filella X. Usefulness of serum tumor markers, including progastrin-releasing peptide, in patients with lung cancer: correlation with histology. Tumour Biol. 2009;30:121\u20139.","journal-title":"Tumour Biol"},{"key":"2941_CR12","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0169-5002(02)00513-5","volume":"39","author":"JL Pujol","year":"2003","unstructured":"Pujol JL, Quantin X, Jacot W, Boher JM, Grenier J, Lamy PJ. Neuroendocrine and cytokeratin serum markers as prognostic determinants of small cell lung cancer. Lung Cancer. 2003;39:131\u20138.","journal-title":"Lung Cancer"},{"key":"2941_CR13","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s00432-022-03970-x","volume":"149","author":"S Zhang","year":"2023","unstructured":"Zhang S, Chen J, Zhang R, Xu L, Wang Y, Yuan Z, Hou X, Feng J. Pulmonary neuroendocrine tumors: study of 266 cases focusing on clinicopathological characteristics, immunophenotype, and prognosis. J Cancer Res Clin Oncol. 2023;149:1063\u201377.","journal-title":"J Cancer Res Clin Oncol"},{"key":"2941_CR14","first-page":"4162","volume":"27","author":"LH Wu","year":"2023","unstructured":"Wu LH, Chen L, Wang QY, Wang YT. Correlation between HRCT signs and levels of CA125, SCCA, and NSE for different pathological types of lung cancer. Eur Rev Med Pharmacol Sci. 2023;27:4162\u20138.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2941_CR15","doi-asserted-by":"publisher","first-page":"500","DOI":"10.4149\/neo_2012_064","volume":"59","author":"X Li","year":"2012","unstructured":"Li X, Asmitananda T, Gao L, Gai D, Song Z, Zhang Y, Ren H, Yang T, Chen T, Chen M. Biomarkers in the lung cancer diagnosis: a clinical perspective. Neoplasma. 2012;59:500\u20137.","journal-title":"Neoplasma"},{"key":"2941_CR16","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s00595-017-1477-y","volume":"47","author":"H Nakamura","year":"2017","unstructured":"Nakamura H, Nishimura T. History, molecular features, and clinical importance of conventional serum biomarkers in lung cancer. Surg Today. 2017;47:1037\u201359.","journal-title":"Surg Today"},{"key":"2941_CR17","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.cca.2020.06.037","volume":"509","author":"J Du","year":"2020","unstructured":"Du J, Li Y, Wang L, Zhou Y, Shen Y, Xu F, Chen Y. Selective application of neuroendocrine markers in the diagnosis and treatment of small cell lung cancer. Clin Chim Acta. 2020;509:295\u2013303.","journal-title":"Clin Chim Acta"},{"key":"2941_CR18","doi-asserted-by":"publisher","first-page":"e38487","DOI":"10.1097\/MD.0000000000038487","volume":"103","author":"C Zhu","year":"2024","unstructured":"Zhu C, Huang J, Jin X, Zhang C, Zhu C, Lv M, Chen S, Du X, Feng G. The predictive value of delta-like3 and serum NSE in evaluating chemotherapy response and prognosis in patients with advanced small cell lung carcinoma: an observational study. Med (Baltim). 2024;103:e38487.","journal-title":"Med (Baltim)"},{"key":"2941_CR19","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/crj.13615","volume":"17","author":"W Li","year":"2023","unstructured":"Li W, Ding C, Sheng W, Wan Q, Cui Z, Qi G, Liu Y. Development and validation of a nomogram for the prediction of brain metastases in small cell lung cancer. Clin Respir J. 2023;17:456\u201367.","journal-title":"Clin Respir J"},{"key":"2941_CR20","doi-asserted-by":"publisher","first-page":"e24865","DOI":"10.1002\/jcla.24865","volume":"37","author":"L Li","year":"2023","unstructured":"Li L, Zhang Q, Wang Y, Xu C. Evaluating the diagnostic and prognostic value of serum TuM2-PK, NSE, and ProGRP in small cell lung cancer. J Clin Lab Anal. 2023;37:e24865.","journal-title":"J Clin Lab Anal"},{"key":"2941_CR21","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1093\/jrr\/rrac035","volume":"63","author":"K Ueki","year":"2022","unstructured":"Ueki K, Matsuo Y, Kishi N, Yoneyama M, Yoshida H, Sakamori Y, Ozasa H, Hirai T, Mizowaki T. Usefulness of pro-gastrin-releasing peptide as a predictor of the incidence of brain metastasis and effect of prophylactic cranial irradiation in patients with limited-stage small-cell lung cancer. J Radiat Res. 2022;63:636\u201345.","journal-title":"J Radiat Res"},{"key":"2941_CR22","doi-asserted-by":"publisher","first-page":"e27029","DOI":"10.1097\/MD.0000000000027029","volume":"100","author":"L Li","year":"2021","unstructured":"Li L, Zhang Z, Hu Y. Neuron - specific enolase predicts the prognosis in advanced small cell lung cancer patients treated with first-line PD-1\/PD-L1 inhibitors. Med (Baltim). 2021;100:e27029.","journal-title":"Med (Baltim)"},{"key":"2941_CR23","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1177\/17246008211049446","volume":"36","author":"Z Chen","year":"2021","unstructured":"Chen Z, Liu X, Shang X, Qi K, Zhang S. The diagnostic value of the combination of carcinoembryonic antigen, squamous cell carcinoma-related antigen, CYFRA 21\u2009\u2013\u20091, neuron-specific enolase, tissue polypeptide antigen, and progastrin-releasing peptide in small cell lung cancer discrimination. Int J Biol Markers. 2021;36:36\u201344.","journal-title":"Int J Biol Markers"},{"key":"2941_CR24","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/crj.13291","volume":"15","author":"C Wang","year":"2021","unstructured":"Wang C, Jin S, Xu S, Cao S. The combination of pretreatment prognostic nutritional index and neuron-specific enolase enhances prognosis predicting value of small cell lung cancer. Clin Respir J. 2021;15:264\u201371.","journal-title":"Clin Respir J"},{"key":"2941_CR25","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1111\/1759-7714.13977","volume":"12","author":"LL Huang","year":"2021","unstructured":"Huang LL, Hu XS, Wang Y, Li JL, Wang HY, Liu P, Xu JP, He XH, Hao XZ, Jiang PD, et al. Survival and pretreatment prognostic factors for extensive-stage small cell lung cancer: a comprehensive analysis of 358 patients. Thorac Cancer. 2021;12:1943\u201351.","journal-title":"Thorac Cancer"},{"key":"2941_CR26","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3892\/ol.2020.12164","volume":"20","author":"M Li","year":"2020","unstructured":"Li M, Han D, Wang W, Zhang Y, Li D, Dai C, Qian L, Lin W. Decline in serum progastrin-releasing peptide predicts the response of patients with small cell lung cancer to chemotherapy. Oncol Lett. 2020;20:301.","journal-title":"Oncol Lett"},{"key":"2941_CR27","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.21037\/jtd.2019.04.29","volume":"11","author":"A Dong","year":"2019","unstructured":"Dong A, Zhang J, Chen X, Ren X, Zhang X. Diagnostic value of ProGRP for small cell lung cancer in different stages. J Thorac Dis. 2019;11:1182\u20139.","journal-title":"J Thorac Dis"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-024-02941-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-024-02941-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-024-02941-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T16:05:52Z","timestamp":1726502752000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-024-02941-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,16]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2941"],"URL":"https:\/\/doi.org\/10.1186\/s12931-024-02941-9","relation":{},"ISSN":["1465-993X"],"issn-type":[{"type":"electronic","value":"1465-993X"}],"subject":[],"published":{"date-parts":[[2024,9,16]]},"assertion":[{"value":"22 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.Informed consent was waived due to the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Cancer Hospital, Chinese Academy of Medical Sciences Ethics Commission (NCC2021C-213).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"341"}}